ACE2 and COVID-19: Therefore, as the portal of virus invasion, the low expression of ACE2 in respiratory epithelial cells of AR patients can reduce the possibility of infection and deterioration of COVID-19 in AR patients, thus counteracting the potential adverse consequences caused by the increase in TMPRSS2 [19,27,29,30].